There is a new name in the very lucrative surgical robotics space -- Titan -- and it wants a piece of Intuitive Surgical's (NASDAQ:ISRG) market. Titan's business model will be very familiar for anyone who knows Intuitive Surgical: Sell a robotic surgery platform to health care facilities, and then design and sell tools for that robot designed to perform specific procedures. It has even named its robot Amadeus, paying tribute to Mozart in the way that Intuitive's da Vinci robot is a nod to Leonardo da Vinci. So if Titan can beat Intuitive's prices, should investors be worried? In this video, Motley Fool analyst Brenton Flynn tells us how these fears are a long way off and a lot needs to happen first. But, he warns, keep an eye on Titan, just in case.

Brenton Flynn has no positions in the stocks mentioned above. The Motley Fool owns shares of Intuitive Surgical and Johnson & Johnson. Motley Fool newsletter services recommend Intuitive Surgical and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.